Optimal timing of the use of an aromatase inhibitor in the adjuvant treatment of postmenopausal hormone receptor-positive breast cancer.

被引：0

作者：

Cuzick, J

Howell, A

机构：

[1] Queen Ma, Wolfson Inst Prevent Med, London, England

[2] Christie Hosp NHS Trust, Manchester M20 4BX, Lancs, England

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：43S / 43S

页数：1

共 50 条

[1] Optimal timing and duration of the use of an aromatase inhibitor (AI) in the adjuvant treatment of postmenopausal hormone receptor-positive (HR+) breast cancer (BC)
Cuzick, J.
[J]. EJC SUPPLEMENTS, 2008, 6 (07): : 121 - 121
[2] DETERMINING THE OPTIMAL TIMING AND DURATION OF THE USE OF AN AROMATASE INHIBITOR (AI) IN THE ADJUVANT TREATMENT OF POSTMENOPAUSAL HORMONE RECEPTOR-POSITIVE (HR plus ) BREAST CANCER (BC) USING MODELLING ANALYSES
Cuzick, J. M.
[J]. ANNALS OF ONCOLOGY, 2008, 19 : 87 - 87
[3] Efficacy of adjuvant aromatase inhibitor in hormone receptor-positive postmenopausal breast cancer patients according to the body mass index
Sendur, M. A. N.
Aksoy, S.
Zengin, N.
Altundag, K.
[J]. BRITISH JOURNAL OF CANCER, 2012, 107 (11) : 1815 - 1819
[4] Efficacy of adjuvant aromatase inhibitor in hormone receptor-positive postmenopausal breast cancer patients according to the body mass index
M A N Sendur
S Aksoy
N Zengin
K Altundag
[J]. British Journal of Cancer, 2012, 107 : 1815 - 1819
[5] Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer
Lippman, Marc
[J]. LANCET ONCOLOGY, 2019, 20 (03): : 312 - 313
[6] Effect of obesity on aromatase inhibitor efficacy in postmenopausal, hormone receptor-positive breast cancer: a systematic review
S. J. Ioannides
P. L. Barlow
J. M. Elwood
D. Porter
[J]. Breast Cancer Research and Treatment, 2014, 147 : 237 - 248
[7] Effect of obesity on aromatase inhibitor efficacy in postmenopausal, hormone receptor-positive breast cancer: a systematic review
Ioannides, S. J.
Barlow, P. L.
Elwood, J. M.
Porter, D.
[J]. BREAST CANCER RESEARCH AND TREATMENT, 2014, 147 (02) : 237 - 248
[8] The effect of using adjuvant aromatase inhibitors on cognitive functions in postmenopausal women with hormone receptor-positive breast cancer
Ilhan, Rukiye Guler
Ilhan, Yusuf
Goksu, Sema Sezgin
Tatli, Ali Murat
Coskun, Hasan Senol
[J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (SUPPL 1) : S368 - S372
[9] Adjuvant Systemic Therapy for Postmenopausal, Hormone Receptor-Positive Early Breast Cancer
Johnston, Stephen R. D.
[J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 37 (01) : 89 - 102
[10] Optimal Timing of Delivery for Women with Hormone Receptor-Positive Breast Cancer
Kuo, Kelly
Senz, Kayli
Caughey, Aaron B.
[J]. OBSTETRICS AND GYNECOLOGY, 2018, 131 : 60S - 60S

← 1 2 3 4 5 →